May 4, 2020 - Axios Events

Gene Therapy and the Future of Disease Treatment

On Monday morning, Axios co-founder Mike Allen and Axios health care business reporter Bob Herman hosted a virtual event on the impact of the coronavirus on biomedical innovations and the challenges of making expensive treatments — like gene therapy — more accessible. They were joined by the U.S. FDA's Director of the Center for Biologics Evaluation and Research Dr. Peter Marks, Rep. Scott Peters (D-Calif.) and Real Endpoints EVP & Chief Clinical Officer Dr. Jane Barlow

Dr. Peter Marks discussed how gene therapy offers "a chance in many ways to to get things right once and for all" as it could potentially save patients a lifetime of needing to undergo disease treatments repeatedly.

  • "With gene therapy, we're going from feeding someone a fish for dinner — in the case of taking regular pills — to teaching them how to fish by taking care of them for a lifetime."

Rep. Scott Peters focused on how targeted treatments can save money in the long term for patients and the government alike.

  • On Congress' traditional resistance to new medical methods: "People, their initial reaction to technologies is that it must be more expensive. It's our job to show that it's more cost-effective over time."

Dr. Jane Barlow discussed rethinking the payment model for expensive treatments like gene therapy. She highlighted how a Netflix-type model could be used to help solve the problem of high one-time costs of gene therapy treatments compared to current medicines where the cost is spread out over time.

Thank you to The Institute for Gene Therapies for sponsoring this event.

Go deeper

Mark Zuckerberg: Social networks should not be "the arbiter of truth"

Photo: Drew Angerer/Getty Images

Facebook CEO Mark Zuckerberg argued on CNBC's "Squawk Box" Thursday that social media platforms should not police political speech, and that "people should be able to see what politicians say.”

Why it matters: Zuckerberg was responding to Twitter's decision this week to fact-check a pair of President Trump's tweets that claimed that mail-in ballots are "substantially fraudulent." Twitter's label, which directs users to "get the facts" about mail-in voting, does not censor Trump's tweets.

House Democrats pull FISA reauthorization bill

Speaker Nancy Pelosi. Photo: Saul Loeb/AFP via Getty Images

House Democrats pulled legislation Thursday that would have renewed expired domestic surveillance laws and strengthened transparency and privacy protections amid broad opposition from President Trump, House GOP leadership and progressive Democrats.

Why it matters: The failure to reauthorize the Foreign Intelligence Surveillance Act (FISA) comes as Trump continues to attack the intelligence community, which he claims abused the law to surveil his 2016 campaign and Trump administration officials.

U.S. GDP drop revised lower to 5% in the first quarter

Data: Bureau of Economic Analysis; Chart: Axios Visuals

The U.S. economy shrunk by an annualized 5% in the first quarter — worse than the initially estimated 4.8% contraction — according to revised figures released by the government on Thursday.

Why it matters: It's the worst quarterly decline since 2008 and shows a huge hit as the economy was just beginning to shut down because of the coronavirus. Economists are bracing for the second quarter's figures to be the worst ever — with some projecting an annualized decline of around 40%.

2 hours ago - Economy & Business